의료 분야 4D 프린팅 시장(2026-2030년)

The global 4d printing in healthcare market is forecasted to grow by USD 226461.5 thousand during 2025-2030, accelerating at a CAGR of 48.2% during the forecast period. The report on the global 4d printing in healthcare market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by surging demand for minimally invasive surgical implants to reduce post-operative complications and shorten hospital stays, paradigm shift toward hyper-personalized patient-specific medicine and adaptive pediatric growth scaffolds, strategic integration of smart bioprinting laboratories directly within major tertiary hospital infrastructures.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global 4d printing in healthcare market is segmented as below:

By Application

• Implants
• Medical devices
• Simulating and training

By Component

• Software and services
• Equipment
• Programmable materials

By Technology

• FDM
• SLA
• SLS
• Bioprinting

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the comprehensive evolution of programmable smart hydrogels for targeted cross-linked chrono-biotic drug delivery networks as one of the prime reasons driving the global 4d printing in healthcare market growth during the next few years. Also, extensive incorporation of multi-material shape-memory alloys within next-generation soft robotics surgical instruments and strategic integration of smart bioprinting laboratories directly within major tertiary hospital infrastructures will lead to sizable demand in the market.

The report on the global 4d printing in healthcare market covers the following areas:

• Global 4d printing in healthcare market sizing
• Global 4d printing in healthcare market forecast
• Global 4d printing in healthcare market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global 4d printing in healthcare market vendors that include 3D Systems Corp., Advanced Solutions, Allevi Inc., Aspect Biosystems Ltd., BICO Group AB, Brinter Oy, CollPlant Biotechnologies Ltd., Cyfuse Biomedical K.K., Fluicell AB, Inventia Life Science Pty Ltd, MATERIALISE NV, Mimix Biotherapeutics Ltd, Organovo Holdings Inc., Poietis, Precise Bio Inc., regenHU Ltd., Renishaw Plc, ROKIT Healthcare Inc., Stratasys Ltd., Tethon 3D LLC. Also, the global 4d printing in healthcare market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by Component
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global 4D Printing In Healthcare Market 2020 - 2024
  • Historic Market Size - Data Table on Global 4D Printing In Healthcare Market 2020 - 2024 ($ thousand)
• 5.2 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ thousand)
• 5.3 Component segment analysis 2020 - 2024
  • Historic Market Size - Component Segment 2020 - 2024 ($ thousand)
• 5.4 Technology segment analysis 2020 - 2024
  • Historic Market Size - Technology Segment 2020 - 2024 ($ thousand)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ thousand)

6 Qualitative Analysis

• 6.1 Impact of AI on global 4D printing in healthcare market
• 6.2 Impact of geopolitical conflicts on global 4D printing in healthcare market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Application

• 8.1 Market segments
• 8.2 Comparison by Application
• 8.3 Implants - Market size and forecast 2025-2030
• 8.4 Medical devices - Market size and forecast 2025-2030
• 8.5 Simulating and training - Market size and forecast 2025-2030
• 8.6 Market opportunity by Application
  • Market opportunity by Application ($ thousand)

9 Market Segmentation by Component

• 9.1 Market segments
• 9.2 Comparison by Component
• 9.3 Software and services - Market size and forecast 2025-2030
• 9.4 Equipment - Market size and forecast 2025-2030
• 9.5 Programmable materials - Market size and forecast 2025-2030
• 9.6 Market opportunity by Component
  • Market opportunity by Component ($ thousand)

10 Market Segmentation by Technology

• 10.1 Market segments
• 10.2 Comparison by Technology
• 10.3 FDM - Market size and forecast 2025-2030
• 10.4 SLA - Market size and forecast 2025-2030
• 10.5 SLS - Market size and forecast 2025-2030
• 10.6 Bioprinting - Market size and forecast 2025-2030
• 10.7 Market opportunity by Technology
  • Market opportunity by Technology ($ thousand)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Israel - Market size and forecast 2025-2030
  • 12.6.6 Argentina - Market size and forecast 2025-2030
  • 12.6.7 South Africa - Market size and forecast 2025-2030
  • 12.6.8 Colombia - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ thousand)
  • Data Tables on Market opportunity by geography ($ thousand)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Surging demand for minimally invasive surgical implants to reduce post-operative complications and shorten hospital stays
  • Paradigm shift toward hyper-personalized patient-specific medicine and adaptive pediatric growth scaffolds
  • Strategic integration of smart bioprinting laboratories directly within major tertiary hospital infrastructures
• 13.2 Market challenges
  • Regulatory ambiguity and evaluation deficiencies in certifying dynamic, shape-shifting materials under existing static guidelines
  • Inadequate multi-material interoperability and low fatigue resistance of programmable biomaterials under physiological loading
  • High capital expenditures for specialized multi-axis bioprinters and extreme shortages of interdisciplinary technical expertise
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Comprehensive evolution of programmable smart hydrogels for targeted cross-linked chrono-biotic drug delivery networks
  • Extensive incorporation of multi-material shape-memory alloys within next-generation soft robotics surgical instruments
  • Strategic integration of smart bioprinting laboratories directly within major tertiary hospital infrastructures

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 3D Systems Corp.
  • 3D Systems Corp. - Overview
  • 3D Systems Corp. - Business segments
  • 3D Systems Corp. - Key offerings
  • 3D Systems Corp. - Segment focus
  • SWOT
• 15.5 Advanced Solutions
  • Advanced Solutions - Overview
  • Advanced Solutions - Product / Service
  • Advanced Solutions - Key offerings
  • SWOT
• 15.6 Allevi Inc.
  • Allevi Inc. - Overview
  • Allevi Inc. - Product / Service
  • Allevi Inc. - Key offerings
  • SWOT
• 15.7 Aspect Biosystems Ltd.
  • Aspect Biosystems Ltd. - Overview
  • Aspect Biosystems Ltd. - Product / Service
  • Aspect Biosystems Ltd. - Key offerings
  • SWOT
• 15.8 BICO Group AB
  • BICO Group AB - Overview
  • BICO Group AB - Business segments
  • BICO Group AB - Key offerings
  • BICO Group AB - Segment focus
  • SWOT
• 15.9 Cyfuse Biomedical K.K.
  • Cyfuse Biomedical K.K. - Overview
  • Cyfuse Biomedical K.K. - Product / Service
  • Cyfuse Biomedical K.K. - Key offerings
  • SWOT
• 15.10 Inventia Life Science Pty Ltd
  • Inventia Life Science Pty Ltd - Overview
  • Inventia Life Science Pty Ltd - Product / Service
  • Inventia Life Science Pty Ltd - Key offerings
  • SWOT
• 15.11 MATERIALISE NV
  • MATERIALISE NV - Overview
  • MATERIALISE NV - Business segments
  • MATERIALISE NV - Key offerings
  • MATERIALISE NV - Segment focus
  • SWOT
• 15.12 Poietis
  • Poietis - Overview
  • Poietis - Product / Service
  • Poietis - Key offerings
  • SWOT
• 15.13 Precise Bio Inc.
  • Precise Bio Inc. - Overview
  • Precise Bio Inc. - Product / Service
  • Precise Bio Inc. - Key offerings
  • SWOT
• 15.14 regenHU Ltd.
  • regenHU Ltd. - Overview
  • regenHU Ltd. - Product / Service
  • regenHU Ltd. - Key offerings
  • SWOT
• 15.15 Renishaw Plc
  • Renishaw Plc - Overview
  • Renishaw Plc - Business segments
  • Renishaw Plc - Key offerings
  • Renishaw Plc - Segment focus
  • SWOT
• 15.16 ROKIT Healthcare Inc.
  • ROKIT Healthcare Inc. - Overview
  • ROKIT Healthcare Inc. - Product / Service
  • ROKIT Healthcare Inc. - Key offerings
  • SWOT
• 15.17 Stratasys Ltd.
  • Stratasys Ltd. - Overview
  • Stratasys Ltd. - Product / Service
  • Stratasys Ltd. - Key offerings
  • SWOT
• 15.18 Tethon 3D LLC
  • Tethon 3D LLC - Overview
  • Tethon 3D LLC - Product / Service
  • Tethon 3D LLC - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations